Pharma channel feed – Endpoints News

Pharma channel feed

US blacklists Chinese research institutes over 'brain control' efforts as investor frets roil biotech stocks

4 years ago

FDA seeks FTC action after rejecting petition to block first generics for decades-old vasopressin

4 years ago

#JPM22 goes virtual, caving to pressure after a wave of big drugmakers pull out due to Omicron fears

4 years ago

Sanofi and GlaxoSmithKline: Those PhIII Covid-19 vaccine results you’ve been waiting for? Wait longer (but here's some booster data)

4 years ago

MarketingRx roundup: J&J’s chief comms officer set to retire; Teva opioid case held up after heated attorney debates

4 years ago

Clinical trials at local pharmacies? A natural fit and more likely than ever: analyst

4 years ago

As dust settles on the Arena buyout, Pfizer exec suggests company will pursue a more aggressive M&A strategy

4 years ago

Senate finance chair to HHS: Wait on Biogen's Aduhelm NCD prior to enforcing historically steep Medicare premium hikes

4 years ago

Q&A: Sanofi's Raj Verma talks connections and pandemic shifts amid new strategy direction

4 years ago

Aim camera for more info? QR codes' popularity portends potential pharma promos

4 years ago

Soothing nature sounds on AbbVie's migraine drug TikTok offer a break from infinite scrolling

4 years ago

Generic drugs and biosimilars get last-minute reprieve from rebates with Senate tweaks to Build Back Better Act

4 years ago

CVS takes a swing at Bristol Myers and Pfizer, excluding coverage of their megablockbuster Eliquis in 2022

4 years ago

Oversight Committee unleashes scathing drug pricing report as Senate preps to vote on allowing Medicare negotiations

4 years ago

As Biohaven CEO Coric preps FDA filing for new migraine spray, he's already scouting for celebrity spokesperson

4 years ago

GlaxoSmithKline enlisted Harris Poll for a severe asthma survey — results point to more outreach

4 years ago

Promising to slim down and speed up, the ‘new’ J&J shakes up the executive committee ahead of the big split

4 years ago

Novartis drafts artist Noma Bar's bold visuals to explain complex MDS blood cancer

4 years ago

Merck KGaA's venture arm is ready to make new investments, raising more than $675M to get things going

4 years ago

Pharma menace Martin Shkreli's old company to pay up to $40M to states for Daraprim price gouging

4 years ago

MarketingRx Matchup: How AbbVie and Biohaven ads rank in head-to-head migraine challenge

4 years ago

Q&A: Organon chief communications officer Wendy Lund talks about the Merck spinoff, women’s health and why it matters

4 years ago

MarketingRx roundup: Pfizer re-ups pneumonia ads as Merck threat looms; Real Chemistry founder CEO Jim Weiss steps back

4 years ago

Digital clutter threatens pharma-to-physician relationships in shift to next era of communications

4 years ago

First page Previous page 230 231 232233234 235 236 Next page Last page